EcTI impairs survival and proliferation pathways in triple-negative breast cancer by modulating cell-glycosaminoglycans and inflammatory cytokines
- PMID: 32841713
- DOI: 10.1016/j.canlet.2020.08.017
EcTI impairs survival and proliferation pathways in triple-negative breast cancer by modulating cell-glycosaminoglycans and inflammatory cytokines
Abstract
Breast cancer is the most common malignant tumor among women worldwide, and triple-negative breast cancer is the most aggressive type of breast cancer, which does not respond to hormonal therapies. The protease inhibitor, EcTI, extracted from seeds of Enterolobium contortisiliquum, acts on the main signaling pathways of the MDA-MB-231 triple-negative breast cancer cells. This inhibitor, when bound to collagen I of the extracellular matrix, triggers a series of pathways capable of decreasing the viability, adhesion, migration, and invasion of these cells. This inhibitor can interfere in the cell cycle process through the main signaling pathways such as the adhesion, Integrin/FAK/SRC, Akt, ERK, and the cell death pathway BAX and BCL-2. It also acts by reducing the main inflammatory cytokines such as TGF-α, IL-6, IL-8, and MCP-1, besides NFκB, a transcription factor, responsible for the aggressive and metastatic characteristics of this type of tumor. Thus, the inhibitor was able to reduce the main processes of carcinogenesis of this type of cancer.
Keywords: Collagen; Inflammation; Metalloprotease; Metastasis; Protease inhibitor.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.J Biol Chem. 2012 Jan 2;287(1):170-182. doi: 10.1074/jbc.M111.263996. Epub 2011 Oct 28. J Biol Chem. 2012. PMID: 22039045 Free PMC article.
-
Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src/EGFR-dependent ITGB4/FAK signaling.Toxicol In Vitro. 2019 Dec;61:104653. doi: 10.1016/j.tiv.2019.104653. Epub 2019 Sep 13. Toxicol In Vitro. 2019. PMID: 31525383
-
Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.Cell Signal. 2017 Apr;32:85-92. doi: 10.1016/j.cellsig.2017.01.021. Epub 2017 Jan 17. Cell Signal. 2017. PMID: 28108260 Free PMC article.
-
All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.Sci Rep. 2018 May 4;8(1):7047. doi: 10.1038/s41598-018-25526-1. Sci Rep. 2018. PMID: 29728589 Free PMC article.
-
Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review.Nutrients. 2023 Dec 19;16(1):2. doi: 10.3390/nu16010002. Nutrients. 2023. PMID: 38201832 Free PMC article. Review.
Cited by
-
The First Anti-Snakebite and Hepatoprotective Characterization of a Trypsin Kunitz-like Inhibitor (EcTI) from the Plant Enterolobium contortisiliquum; A Case of Two Soul Mates Meeting.Pharmaceuticals (Basel). 2023 Apr 21;16(4):632. doi: 10.3390/ph16040632. Pharmaceuticals (Basel). 2023. PMID: 37111388 Free PMC article.
-
Proliferation and Invasion of Melanoma Are Suppressed by a Plant Protease Inhibitor, Leading to Downregulation of Survival/Death-Related Proteins.Molecules. 2022 May 5;27(9):2956. doi: 10.3390/molecules27092956. Molecules. 2022. PMID: 35566311 Free PMC article.
-
Peptides Derived from a Plant Protease Inhibitor of the Coagulation Contact System Decrease Arterial Thrombus Formation in a Murine Model, without Impairing Hemostatic Parameters.J Clin Med. 2023 Feb 23;12(5):1810. doi: 10.3390/jcm12051810. J Clin Med. 2023. PMID: 36902597 Free PMC article.
-
Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors.Molecules. 2024 Aug 16;29(16):3891. doi: 10.3390/molecules29163891. Molecules. 2024. PMID: 39202970 Free PMC article. Review.
-
Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets.Int J Mol Sci. 2022 Apr 25;23(9):4742. doi: 10.3390/ijms23094742. Int J Mol Sci. 2022. PMID: 35563133 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
